Global Protein Engineering Market to Reach US$ 7.8 Billion by 2032, Propelled by Shifting Focus Toward Protein-Based Drug Development

February 16, 2022 | Healthcare

The latest report by IMARC Group, titled "Protein Engineering Market Report by Product & Services (Instruments, Reagents, Services and Software), Protein Type (Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Others), Technology (Irrational Protein Design, Rational Protein Design), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), and Region 2024-2032," finds that the global protein engineering market size reached US$ 3.3 Billion in 2023. Protein engineering refers to the process that involves the synthesis of new proteins or manipulation of the existing protein structure or sequence to achieve the desired properties. It utilizes the recombinant deoxyribonucleic acid (DNA) technology or chemical synthesis to alter the individual amino acids in a normal protein to develop a novel protein with enhanced functions, such as better stability to the temperature, organic solvents, or extremes of pH. Over the years, protein engineers and researchers have successfully developed a wide range of proteins or enzymes tailored to specific industrial, medical, research, and biotechnology applications.

Global Protein Engineering Market Trends:

The shifting focus toward protein-based drug development coupled with heavy investments in synthetic biology represents the primary factor driving the market growth. Besides this, the growing inclination from non-protein drugs toward protein therapeutics due to the rising awareness regarding their positive clinical outcomes among the masses has augmented the demand for protein engineering. Additionally, governments of various countries are taking favorable initiatives, such as funding research and development (R&D) projects and organizing awareness programs about protein engineering. Along with this, the widespread prevalence of protein-deficient diseases and the escalating demand for personalized medicines have accelerated the adoption of protein engineering. Furthermore, the rising adoption of monoclonal antibodies to treat numerous diseases, including cancer, autoimmune disorders, transplant rejections, and other conditions, has catalyzed the market growth. Moreover, the advent of recombinant monoclonal antibodies (mAbs), emerging applications in the agrochemical industry, improving healthcare infrastructure, increasing investments in proteomics-based drug discovery projects, and technological advancements are some of the other factors creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 7.8 Billion by 2032, growing at a CAGR of 9.9% during 2024-2032. 

Market Summary:

  • Based on the product and services, the market has been divided into instruments, reagents, and services and software. 
  • On the basis of the protein type, the market has been segregated into insulin, monoclonal antibodies, coagulation factors, vaccines, growth factors, and others. 
  • Based on technology, the market has been bifurcated into irrational and rational protein design.
  • The market has been classified based on the end user into pharmaceutical and biotechnology companies, academic research institutes, and contract research organizations. 
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc, Thermo Fisher Scientific Inc., and Waters Corporation.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product & Services, Protein Type, Technology, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Protein Engineering Market to Reach US$ 7.8 Billion by 2032, Propelled by Shifting Focus Toward Protein-Based Drug Development
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More